Reported about 12 hours ago
Bain Capital is close to finalizing a deal to acquire Mitsubishi Chemical Group's pharmaceutical division, with the transaction potentially valued at over $3 billion. This acquisition is part of a broader trend of increased deal-making activity in Japan, as Bain emerges as the leading bidder against other investment firms. While details are still being negotiated and no final agreements are in place, an announcement could come as soon as Friday.
Source: YAHOO